ACST stock results show that Acasti Pharma beat analyst estimates for earnings per share the fourth quarter of 2024. More
Articles
Biden Bans Kaspersky Antivirus Software Sales: What to Know Next
Kaspersky antivirus software sales have been banned in the U.S. by the Biden administration over its ties to the Russian government. More
The Emperor’s New Stocks: 3 Overhyped Picks That Are Naked Beneath the Buzz
These overhyped stocks to sell are riding high, but traders would be dumping all three of these companies if they knew the whole story. More
Mark Your Calendars: The Student Loan Forgiveness Deadline Is June 30
The student loan forgiveness deadline is quickly approaching as students only have until June 30 to consolidate their debts. More
Stock Market Crash Alert: Mark Your Calendars for June 28
The May PCE report is due Friday, June 28. The results of which could determine whether the Fed cuts rates. Will the stock market crash? More
3 Stocks the Top Billionaires Are Betting Big on in 2024
Consider following the smart money with these three stocks billionaires are betting on in 2024, as they could deliver market-beating gains. More
